Jove
Visualize
Contact Us

Related Experiment Videos

Antiviral drugs.

E H Wiltink1, R Janknegt

  • 1Department of Pharmacy, University of Medical Centre, Amsterdam, The Netherlands.

Pharmaceutisch Weekblad. Scientific Edition
|April 26, 1991
PubMed
Summary

Effective antiviral drugs are scarce, particularly for human immunodeficiency virus (HIV) treatment and secondary infections in acquired immunodeficiency syndrome (AIDS). Research is urgently needed to combat drug-resistant viral strains.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The nocebo effect challenges the non-medical infliximab switch in practice.

European journal of clinical pharmacology·2018
Same author

The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs.

European journal of clinical pharmacology·2017
Same author

Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

The journal of nutrition, health & aging·2016
Same author

SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.

The Netherlands journal of medicine·2012
Same author

[Prolonged diminished effect of coumarin derivatives after use of rifampicin].

Nederlands tijdschrift voor geneeskunde·2007
Same author

[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].

Nederlands tijdschrift voor geneeskunde·2006
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Virology
  • Infectious Diseases

Background:

  • Limited availability of effective, non-toxic antiviral medications presents a significant clinical challenge.
  • There is a critical need for novel antiviral therapies, especially for human immunodeficiency virus (HIV) infections and secondary infections associated with acquired immunodeficiency syndrome (AIDS).
  • The emergence of drug-resistant viral strains is an escalating global health concern.

Purpose of the Study:

  • To review currently available antiviral drugs.
  • To discuss their antiviral properties, mechanisms of action, clinical applications, pharmacokinetics, and side effects.
  • To explore future research directions in the development of new anti-HIV drugs.

Main Methods:

  • Literature review of existing antiviral drugs.
  • Analysis of drug properties, including efficacy, toxicity, and resistance profiles.
  • Discussion of clinical use and pharmacokinetic data.
  • Exploration of emerging research trends.

Main Results:

  • Current antiviral drug options are limited, with significant challenges in treating HIV and AIDS-related viral infections.
  • Drug resistance is a growing problem, necessitating the development of new therapeutic agents.
  • A comprehensive review of existing drugs' properties and a look towards future strategies are presented.

Conclusions:

  • The development of new, effective, and non-toxic antiviral drugs, particularly for HIV, is a high priority.
  • Addressing drug resistance and secondary infections in AIDS patients requires continued research and innovation.
  • Further investigation into novel antiviral agents and therapeutic strategies is essential for improving patient outcomes.

Related Experiment Videos